A new device called the Liberty, which allows cancer patients to conduct blood tests at home, has received regulatory approval. This device enables patients to avoid frequent hospital visits by facilitating at-home blood sampling and result uploads, significantly reducing stress and increasing convenience. Although it has been successfully trialed in a small study at The Christie in Manchester, further research is necessary to confirm its wider applicability in cancer care, according to Cancer Research UK. The device is now set to be deployed at 12 NHS sites.
Test-at-home kit for cancer patients approved for use (BBC)
0![Test-at-home kit for cancer patients approved for use (BBC)](https://scopeforward.com/wp-content/uploads/2024/05/133290041_image.jpg.webp)